Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SOCS3 (suppressor of cytokine signaling 3) inhibits the intracellular signaling cascade initiated by exposure of cells to cytokines. SOCS3 regulates signaling via two distinct mechanisms: directly inhibiting the catalytic activity of Janus kinases (JAKs) that initiate the intracellular signaling cascade and catalysing the ubiquitination of signaling components by recruiting components of an E3 ubiquitin ligase complex. Here we investigate the latter mode-of-action biochemically by reconstructing a SOCS3-based E3 ubiquitin ligase complex in vitro using fully purified, recombinant components and examining its ability to promote the ubiquitination of molecules involved in the cytokine signaling cascade. We show that SOCS3 is an active substrate recruitment module for a Cullin5-based E3 ligase and have defined the core protein components required for ubiquitination. SOCS3-induced polyubiquitination was rapid and could proceed through a number of different ubiquitin lysines. SOCS3 catalyzed the ubiquitination of both the IL-6 receptor common chain (gp130) and JAK2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507 · cited 5×
“Cullin5, co-expressed with Rbx1 or Rbx2, was produced as two separate domains as first demonstrated for Cullin1 by Zheng et al. (2002); these associate with each other and with Rbx2, during expression and could be isolated as a ternary [Cul5(NTD):Cul5(CTD):Rbx2] complex (Figure 1A, Lane 1).”
BackgroundInfluentialSOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904 · cited 3×
“While E3 ligase activity has been demonstrated for a number of SOCS box-containing proteins (Kuang et al., 2010), of the eight members of the SOCS family, only for SOCS1, which promotes the degradation of the TEL-JAK oncoprotein (Kamizono et al., 2001), vav (De Sepulveda et al., 2000), IRS-1 and IRS-2 (Rui et al., 200…”
BackgroundSOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840 · cited 2×
“SOCS3 regulates the response to IL-6 (Croker et al., 2003), G-CSF (Croker et al.”
BackgroundSelf-citationDuda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767 · cited 8×
“…near the E2 ubiquitin-docking site and enhances the ubiquitin ligase efficiency by inducing a substantial conformational change in the Cullin scaffold such that the E2 is released from the core of the complex, allowing it more efficient access to the substrate lysine side chain (Duda et al., 2008).”
BackgroundInfluentialYasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719 · cited 1×
“The primary mechanism of SOCS3 action is via direct inhibition of the catalytic activity of JAKs (Janus kinases) (Sasaki et al., 1999, 2000; Yasukawa et al., 1999).”
BackgroundMori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., Nishinakamura, H., Torisu, T., Chien, K. R., Yasukawa, H., & Yoshimura, A. (2004) · Nature Medicine · doi:10.1038/nm1071 · Cited by 651 · cited 2×
“SOCS3 regulates the response to IL-6 (Croker et al., 2003), G-CSF (Croker et al., 2004), leukemia inhibitory factor (Roberts et al., 2001) and leptin (Mori et al., 2004) and binds to both the cytoplasmic domains of the receptors for those cytokines as well as to the receptor-bound JAKs.”
BackgroundNicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., Zhang, J.-G., Silva, A., Asimakis, M., Farley, A., Nash, A. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100135197 · Cited by 456
Self-citationSasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00263.x · Cited by 398 · cited 1×
“The primary mechanism of SOCS3 action is via direct inhibition of the catalytic activity of JAKs (Janus kinases) (Sasaki et al., 1999, 2000; Yasukawa et al., 1999).”
BackgroundThe SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010074200 · Cited by 311 · cited 4×
“, 2010), of the eight members of the SOCS family, only for SOCS1, which promotes the degradation of the TEL-JAK oncoprotein (Kamizono et al., 2001), vav (De Sepulveda et al.”
BackgroundInfluentialKershaw, N. J., Murphy, J. M., Liau, N. P. D., Varghese, L. N., Laktyushin, A., Whitlock, E. L., Lucet, I. S., Nicola, N. A., & Babon, J. J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2519 · Cited by 301
Self-citationSOCS3 Is a Critical Physiological Negative Regulator of G-CSF Signaling and Emergency Granulopoiesis
Croker, B. A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., DiRago, L., Cluse, L. A., Sutherland, K. D., Hartley, L., Williams, E., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00022-6 · Cited by 285
Self-citationBabon, J. J., Kershaw, N. J., Murphy, J. M., Varghese, L. N., Laktyushin, A., Young, S. N., Lucet, I. S., Norton, R. S., & Nicola, N. A. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.015 · Cited by 279
Self-citationBabon, J. J., McManus, E. J., Yao, S., DeSouza, D. P., Mielke, L. A., Sprigg, N. S., Willson, T. A., Hilton, D. J., Nicola, N. A., Baca, M., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.024 · Cited by 163 · cited 1×
“The SOCS3 construct lacked the first 21 residues and had the PEST motif replaced by a short Gly-Serx4 linker (Babon et al., 2005, 2006) as these modifications enhance solubility but are not required for function.”
BackgroundSelf-citationUbiquitin Transfer from the E2 Perspective: Why is UbcH5 So Promiscuous?
Brzovic, P. S., & Klevit, R. E. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3592 · Cited by 89 · cited 1×
“Three of these E2 enzymes, the related UbcH5a, UbcH5b and UbcH5c, gave the most robust ubiquitination (with both Rbx1 and Rbx2), as seen previously for a number of different E3 ligase systems (Brzovic & Klevit, 2006; Saha & Deshaies, 2008).”
BackgroundMolecular Architecture of the Ankyrin SOCS Box Family of Cul5-Dependent E3 Ubiquitin Ligases
Muniz, J. R. C., Guo, K., Kershaw, N. J., Ayinampudi, V., von Delft, F., Babon, J. J., & Bullock, A. N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.06.015 · Cited by 34 · cited 3×
“Models of SOCS-based E3 ligases suggest that there is480 Å between the substratebinding site and the reactive cysteine of the E2 enzyme when it is docked onto the SOCS–elonginBC–Cullin5–Rbx2 scaffold (Bullock et al., 2006, 2007; Muniz et al., 2013).”
BackgroundMethodSelf-citation
Cited by
Interleukin-6: Biology, signaling and strategies of blockade
Schaper, F., & Rose-John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 509
Leukemia inhibitory factor (LIF)
Nicola, N. A., & Babon, J. J. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.001 · Cited by 478
Self-citationElusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453
“SOCS3 overexpression prevented the nuclear accumulation of STAT3 Frontiers in Cellular Neuroscience | www.frontiersin.org 7 August 2015 | Volume 9 | Article 278 FIGURE 2 | Activation of the JAK/STAT3 pathway is a common feature of astrocyte reactivity in various ND models.”
BackgroundInfluentialA human multi-lineage hepatic organoid model for liver fibrosis
Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26410-9 · Cited by 149
Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down
Liu, Y.-X., Dong, X., Gong, F., Su, N., Li, S.-B., Zhang, H.-T., Liu, J.-L., Xue, J.-H., Ji, S.-P., & Zhang, Z. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135259 · Cited by 5
Metadata
- Authors
- Kershaw, N. J., Laktyushin, A., Nicola, N. A., & Babon, J. J.
- Venue
- Growth Factors
- Publisher
- Informa UK Limited
- Published
- 2014-01-20
- Volume
- 32
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0897-7194 (ISSN-L)
- 1029-2292
- OpenAlex
- W2063937332
- Cited by
- 42
- References
- 16
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.